Literature DB >> 21979255

[Psoriatric arthritis - a permanent challenge for rheumatologists and patients: part 2: imaging diagnostics, classification and therapy].

S Finzel1, M Englbrecht.   

Abstract

In recent years a considerable number of imaging techniques have been used to demonstrate the onset and progression of arthritis-related changes in psoriatric arthritis (PsA). Moreover the identification of new immunological pathways has resulted in a substantial improvement of available therapies for PsA increasing the chance for the individual to receive effective treatment. Although an all-embracing disease activity score is still lacking, there is a variety of symptom-related tools to adequately reflect the course of disease and to evaluate the corresponding treatment success. This manuscript aims to give an overview of the latest corresponding knowledge with respect to PsA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979255     DOI: 10.1007/s00393-011-0870-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  104 in total

Review 1.  Therapies for axial disease in psoriatic arthritis. A systematic review.

Authors:  Peter Nash
Journal:  J Rheumatol       Date:  2006-05-15       Impact factor: 4.666

2.  A method to score radiographic change in psoriatic arthritis.

Authors:  S Wassenberg; V Fischer-Kahle; G Herborn; R Rau
Journal:  Z Rheumatol       Date:  2001-06       Impact factor: 1.372

Review 3.  Infliximab treatment for rheumatic disease: clinical and radiological efficacy.

Authors:  E W St Clair
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

4.  The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography.

Authors:  R J Wakefield; W W Gibbon; P G Conaghan; P O'Connor; D McGonagle; C Pease; M J Green; D J Veale; J D Isaacs; P Emery
Journal:  Arthritis Rheum       Date:  2000-12

5.  Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.

Authors:  Wolfram Sterry; Jean-Paul Ortonne; Bruce Kirkham; Olivier Brocq; Deborah Robertson; Ronald D Pedersen; Joanne Estojak; Charles T Molta; Bruce Freundlich
Journal:  BMJ       Date:  2010-02-02

6.  Remission in psoriatic arthritis.

Authors:  Kurt de Vlam; Rik J U Lories
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

7.  Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

Authors:  L Williamson; N Dalbeth; J L Dockerty; B C Gee; R Weatherall; B P Wordsworth
Journal:  Rheumatology (Oxford)       Date:  2004-04-27       Impact factor: 7.580

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.

Authors:  J Peter Kaltwasser; Peter Nash; Dafna Gladman; Cheryl F Rosen; Frank Behrens; Peter Jones; Jürgen Wollenhaupt; Franziska G Falk; Philip Mease
Journal:  Arthritis Rheum       Date:  2004-06

10.  A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience.

Authors:  D Kane; L Stafford; B Bresnihan; O FitzGerald
Journal:  Rheumatology (Oxford)       Date:  2003-10-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.